Recently the FDA began a review of trial results for the experimental drug Ampligen® as a therapy for Chronic Fatigue Syndrome (ME/CFS). This means that after many years of trials involving various leading ME/CFS specialists, within a few months this drug might become the first to be approved  for prescription to patients in the US. If this comes about, ME/CFS patients and their physicians will have some collaborative decisions to make.
If you have a diagnosis of ME/CFS, please take a moment to complete this brief, anonymous survey. Check all boxes that apply.
Subscribe to the World's Most Popular Newsletter (it's free!)
Create your free online surveys  with SurveyMonkey, the world’s leading questionnaire tool.